---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "bn+BQhupMVcsA/TsPfGf8mrQLsuH0FeGpR1vl08baaj5EeikxY5G/9bQ5V8W9HApDbbSL6wbV4YseeI+KNkqgZt3xusc9c3A0jh/Hr1+RcCMTEK+dPGfbvVoGv8qHdX1ybGJIo8D1USyRwefrxPx+xyBJihVJi/5vcVUXip4yo3+VJ6iR/dQDcBiu+kozecxXc+cYWZTfQj/emp3wASMn9AsrjglfaKI3tF7EuOl/lNAntR8tzOsS9jsCi7JbyG8W75f/cLpZ6jt/IPe3HoQB/nbUnRXr//gSTmrO115O0NdLEp9QiVQgt95NXVMxnbgcueon6/5AKzLdqo9297w6c0WPzRjxNEI+AlUiZ+PGAQ=;i5Q3mj1db7VJzUt0E0DyqQ=="
---

